Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations

Wael M. Abdel‐Rahman(University of Sharjah), Maha Saber-Ayad(University of Sharjah)

World Journal of Gastroenterology

January 1, 2017

10.3748/wjg.v23.i19.3440

Cited by 30

Related Papers

Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021

|The Lancet|2025|801

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

|The Lancet|2025|386

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

|The Lancet|2025|259

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023

|The Lancet|2025|99

Investigating the Impact of IL6 on Insulin Secretion: Evidence from INS-1 Cells, Human Pancreatic Islets, and Serum Analysis

|Cells|2024|2